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Introduction
Alcohol is one of the most preventable causes of injury and 
mortality in the world and is one of the major risk factors for 
diseases.1,2 Across the world, adult alcohol consumption has 
been around 38% over the past 12 months.3 According to a 
study published in 2011, alcohol accounts for 4% of cancers in 
the UK.4 Most importantly, alcohol is a major risk factor for 
cancer. Evidence related to the role of alcohol in cancer related 
to the early 20th century.5 Epidemiologic studies and numerous 
meta-analysis have supported this relationship.5 So, the Inter-
national Agency for Research on Cancer (IARC) in 1988 cate-
gorized alcohol as a group one of carcinogens (the highest level 
in terms of risk).6 After the digestion and processing of alcohol 
in the body, it is changed to a kind of chemical called acetalde-
hyde, which is the group one carcinogen2,8 and prevents DNA 
repair, subsequently increases the risk of cancer.7 Several epi-
demiological studies have examined the relationship between 
alcohol drinking and the risk of developing cancer. Based on 
findings from epidemiological studies, alcohol consumption 
elevates the risk of various cancers such as breast and intes-
tine8,9 and is one of the main risk factors for liver malignan-
cies.10 In 2007, the IARC concluded that there is ample evidence 
that alcohol causes cancer of the mouth, throat, esophagus, 
larynx, and colorectal.11 In some malignancies, such as pros-
tate cancer, this relationship is dose- dependent.12 In some 
other tumors, even taking a small amount of alcohol can 
increase the risk of cancer; as an illustration, it is associated 
with colon cancer for every two units of alcohol per day (each 
unit is 10 ml or 8 g) that risk of malignancy is expanded by 
9%.14 However, the findings of previous studies suggested that 
alcohol could reduce the risk of non-Hodgkin’s lymphoma 
(NHL), thyroid cancer and renal cell carcinoma, but the find-
ings of the studies were inconsistent.15–17
So far, a large prospective study has examined the rela-
tionship between alcohol consumption and cancer risk. 
However, due to the low number of cases and the existence of 
contradictory results, in most types of cancers no definitive 
findings have been reported and the epidemiological evi-
dence that systematically addressed is limited. Therefore, this 
study aimed to investigate the relationship between alcohol 
consumption and common cancers of various organs of the 
body, taking into account possible confounding variables for 
each organ based on existing evidence and review of the 
literature.
Materials and Methods
This study was conducted in English by February 2019 to 
include epidemiological evidence from all available rand-
omized control trials, case-control and cohort studies 
reporting alcohol consumption related cancer risks through a 
search in data bases of the PubMed, Scopus and Web of 
 Science. The search strategy included the keywords: “cancer”, 
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“alcohol consumption or alcohol drinking or underage 
drinking”. In addition, the reference lists of relevant articles 
were manually searched to find any other potentially eligible 
articles. Articles about alcohol consumption amount and types 
of alcohol beverage are also included in the present study. We 
excluded reviews, commentaries, articles from overlapping 
samples, conference abstracts, and articles printed in lan-
guages other than English. Articles that looked at the relation-
ship between each type of cancer and alcohol consumption 
were entered in to the study and summarized in review.
Results
Study Characteristics
In the initial electronic literature search, 2236 articles were 
obtained from data bases and 43 articles were obtained using 
manual search. After removing duplicates using Endnote X7 
(n = 1279), the title and abstract of the remaining 1000 arti-
cles were reviewed. After this stage, 166 articles were included 
in the study and 38 of these articles were removed because of 
scientific reasons and lack of eligible criteria or unrelated to 
our aim, in all, 128 full papers were reviewed. The most 
important cancers related to alcohol consumption are sum-
marized in Table 1.
Types of Alcohol-related Cancers
Oral and Pharyngeal Cancer
The findings of a review study between 1988 and 2009 indi-
cated that alcohol consumption is a risk factor for oral and 
throat cancers, and if combined with tobacco, this effect is 
multiplied and synergist. On the other hand, the findings 
revealed that even after controlling for smoking, alcohol con-
sumption was still a risk factor for oral and thymus cancer.18 
Meta-analysis study findings also showed that the risk of oral 
and throat cancer in alcoholics is dose-dependent.19 The find-
ings of two meta-analysis studies of more than 30 studies with 
14,000 cases showed a significant relationship between alcohol 
intake and the risk of oral and pharyngeal cancer (OPC), 
depending on the dose (relative risks, RRs, increasing from 
1.29 for 10 g ethanol/day to 13.02 for 125 g ethanol/day).19 
There is a higher RR for cancer of the throat compared with 
oral cancer, especially in heavy dose.20 It is estimated that 30% 
of all OPCs worldwide are attributed to alcohol consump-
tion.21 Findings from several cohort studies in the United 
States, Europe and Asia24–22 reported increased risk of oral and 
throat cancer in alcohol users. Adami et al.25 found in a cohort 
study in Sweden that the risk of oral and throat cancer in alco-
holics was four times higher than that of non-alcoholic people 
(95% CI: 2.9–5.6). Tønnesen et al.26 also reported that the risk 
of oral and thoracic cancers in alcoholic men was 3.5 times 
higher than that of non-alcoholic men (95% CI: 3.0–4.3) and 
in alcoholic women was 15 times less than non-alcoholic 
women (95% CI: 10.8–26.0). In oral and thymus cancer the 
harmful effects of alcohol in both the intracellular and extra-
cellular levels is observed. In this regard, carcinogens can 
affect the proliferative activity of the stem cells in basal layer. 
In patients with oral and thoracic cancer, there is a significant 
increase in salivary acetaldehyde concentration, which can be 
related to smoking and poor oral health. Acetaldehyde pro-
duction can also be increased by alcohol intake through bacte-
rial fluoride.27
Laryngeal Cancer
The association between receiving alcoholic drinks and the 
spread of laryngeal cancer was first reported in the early 1900s 
through clinical reports and mortality statistics, and then con-
firmed by ecological studies.28–30 Several studies have con-
firmed the role of alcohol in laryngeal cancer.31,32 The findings 
of a meta-analysis study in North America, Europe, Japan, and 
Korea also showed that the risk of laryngeal cancer is signifi-
cantly elevated if more than one unit of alcohol per day is 
received.33 This risk also increases in non-smokers.34 Drinking 
alcohol through direct contact or solvent action affects laryn-
geal cancer.35 It is estimated that between 50% and 70% of all 
esophageal cancer cases are attributed to alcohol in both 
sexes.36 Ethanol changes the motility and tone of the lower eso-
phagus, the gastric reflux to the esophagus after esophagitis.37 
This condition increases the risk of Barrett’s esophagus or 
intestinal metaplasia, dysplasia and adenocarcinoma. Chronic 
inflammation causes more esophagus mucosal damage to 
nitrosamines and polycyclic aromatic carbohydrates. These 
ingredients are present in alcoholic drinks.38 The relationship 
between alcohol consumption and the risk of esophageal 
cancer in various studies (prospective and case-control) has 
been reported worldwide.39,40 In the most recent evaluation by 
IARC, ethanol in alcoholic drinks has been grouped as one of 
the carcinogens for humans.41 In a second report published by 
the American Cancer Research Association, alcohol was iden-
tified as one of the escalating causes of esophageal cancer.42 
Therefore, drinking alcohol is known as one of the risk factors 
for esophageal cancer.
The risk of esophageal malignancy is dose- 
dependent.1,43,44 When alcohol is consumed with smoking, 
the relative risk (RR) of the disease increases significantly. In 
case of 20 cigarettes per day with one to four units per day, 
RR increases by 1.5 times. By taking four to eight units per 
Table 1. Relationship between alcohol consumption and 
cancer types
Cancer types Risk factor Protective Controversial
Oral and pharyngeal 
cancer
*
Laryngeal cancer *
Esophagus *
Stomach *
Colorectal *
Liver *
Pancreas *
Lung *
Prostate *
Bladder *
Breast *
Endometrium *
Renal cell carcinoma *
Brain tumor *
Non-Hodgkin  
lymphoma
*
236 J Contemp Med Sci | Vol. 5, No. 5, September-October 2019: 234–241
Alcohol consumption and types of cancer: a review
Review
M. Afshar et al.
day, RR increases to 12.3; and if you take more than eight 
units per day, RR will increase 44.4-fold.45 Given that most 
alcoholics, addicts to tobacco, the synergistic effects of this 
compound are very important.43 The findings of a meta- 
analysis study showed that alcohol consumption could 
increase the risk of gastric cancer with odds ratio (OR) of 
39/1 (95% CI: 1.20–1.61), even in the case of low alcohol 
consumption.46 Findings from several recent studies have 
reported that drinking alcohol can increase the risk of gastric 
cancer, and its main mechanism is probably related to pri-
mary metabolites and stalled individuals, which has a topical 
toxic effect and soars the risk of gastric cancer.
Stomach
The findings of a meta-analysis study revealed that alcohol 
consumption even in the case of low dose could increase the 
risk of gastric cancer with odds ratio (OR) of 39/1 (95% CI: 
1.20–1.61).46 Findings from several recent studies have 
reported that drinking alcohol can raise the risk of gastric 
cancer, and its main mechanism is probably related to primary 
metabolites and acetaldehydes, which has a topical toxic effect 
and increases the risk of gastric cancer.47,48 The relationship 
between drinking alcohol and the risk of gastric cancer is 
 biologically plausible; ethanol is one of the soluble fats and 
may cause damage to the stomach mucosa. Acetaldehyde 
metabolite may have a topical toxic effect that may be related 
to gastric cancer.49 Ethanol pathogenesis is associated with 
gastric mucosal injury with impairment in the balance of gas-
tric mucus defense and external invasion.50,51
Colorectal
Several epidemiological studies have shown that increasing 
alcohol consumption is one of the risk factors for colorectal 
cancer. The findings of the review and meta-analysis 
studies8,52–54 and several meta-analysis surveys on case and 
control cohort studies indicate that alcohol intake is associated 
with an elevation in colorectal cancer.55,56 The findings of sev-
eral meta-analysis studies showed a positive relationship 
between alcohol consumption and colorectal cancer, and this 
relationship is dose-dependent.43,57,58 Several studies also 
found that with a chronic consumption of about 50 g per day 
of alcohol, the relative risk of colon cancer was 10–20%.43,59 
The findings of Dashti et al.60 revealed that alcohol consump-
tion, especially more than 28 g per day of ethanol, is associated 
with colon cancer.
Liver
Several studies in various countries have examined the rela-
tionship between alcohol consumption and the risk of devel-
oping liver cancer (also called HCC) and have confirmed this 
relationship.61–63 Based on systematic and meta-analytic find-
ings, the relative risk of liver cancer for low levels, hazardous 
and harmful of alcohol consumption, as compared with those 
who have never consumed alcohol, is respectively 1.45%, 
0.33%, and 3.60% (low consumption = 0–19.90 g for females 
and 039.99 g for males, pure alcohol per day), hazardous con-
sumption = (females 20–39.99 g, males 40–59.99 g), harmful 
consumption = (females 40+ g, males 60+ g).64
The main role of gastric cancer following alcohol using is 
acetaldehyde produced by bacterial flora.43 The findings from 
a meta-analysis study on 19 cohort studies estimated an 
increase of 16% in liver cancer among those who consumed at 
least three units of alcohol daily, compared with non-infected 
individuals.65 In fact, in alcoholic people, prolonged and severe 
alcohol consumption leads to alcoholic cirrhosis, which is a 
pathogenic stage in liver carcinogenesis.66 Along with the car-
cinogenicity of acetaldehyde, which is the first metabolite of 
alcohol, other biological mechanisms also explain the effect of 
alcohol consumption on hepatocarcinogenesis. These include 
chronic inflammation, the consequences of increased oxida-
tive stress, the induction of cytochrome P-450 2E1, lipid per-
oxidation and DNA damage, diminished antioxidant defense 
and DNA repair, reduction of hepatic retinoic acid, excess iron 
loading, and immune deficiency.67
Pancreas
Findings from a prospective study in the United States revealed 
that alcohol consumption, in particular consumption liquor, 
at least three units per day increased pancreatic cancer inde-
pendent of smoking.68 Although the findings of some cohort 
studies62,69,70 and three meta-analysis studies71–73 showed that 
there is a positive and significant relationship between alcohol 
consumption and the risk of pancreatic cancer, other cohort 
studies72,74,75 did not reveal this relationship. Heavy alcohol 
consumption causes acute and chronic pancreatitis, but has 
never been associated with liver cancer.68 Findings from a 
meta-analysis study in 2016 demonstrated that low to mod-
erate alcohol intake did not significantly correlate with the risk 
of pancreatic cancer, while receiving high amounts of alcohol 
as well as alcohol drinks increase the risk of pancreatic cancer.76 
Several biological mechanisms have been proposed to explain 
the increased risk of pancreatic cancer following heavy alcohol 
use. Alcohol can cause to inflammatory responses that would 
lead to overt chronic pancreatitis or diabetes mellitus by 
inducing mitogenic stimulation.77,78 Alcohol consumption also 
causes asymptomatic chronic pancreatitis, which eventually 
results in pancreatic cancer,79–81 although the prevalence of 
pancreatitis history in the total population of patients with 
pancreatic cancer is very low.
Lung
An elevated risk of lung cancer in the general population has 
been reported in numerous cohort studies.43 The findings of 
the study, Korte et al.,82 revealed that for doses greater than five 
units per day, the relative risk was between 1.53 and 1.88. 
There is a positive correlation between alcohol consumption 
and lung cancer in several reported studies.83–85 However, the 
protective effect of low to moderate alcohol in reducing the 
incidence of lung cancer has been reported in several 
studies.85–87 Rohrmann et al.86 found that the anti- inflammatory, 
antioxidant, and anti-mutagenic effects of intermediate eth-
anol produce protective effects. Although this protective effect 
is only specific for lung cancer and is not observed for other 
neoplasms.88
Prostate
Over the past few decades, a number of overviews and 
meta-analysis have examined the relationship between pros-
tate cancer and alcohol consumption.89–92 According to the 
findings of Longnecker91 and Morton et al.,90 there was no 
association between alcohol consumption and prostate cancer. 
Breslow and Weed93 reviewed 32 studies and reported only six 
studies that found association between alcohol consumption 
and prostate cancer.
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The findings of Dennis’s93 meta-analysis on six cohorts 
and 27 cases-control did not confirm this relationship. 
 Dagnelie et al.89 reviewed nine prostate cancer and alcohol 
studies, and found that in six studies, such a relationship was 
not confirmed; in two studies, the risk was increased and 
decreased in one study. The findings of the meta-analysis88 
showed that the small, but significant risk of prostate cancer in 
men who consumed more than 50 g of alcohol per day was 
observed at a higher risk for men who consumed more than 
100 g per day of alcohol, but there was no significant dose–
response relation. This study first considered potential con-
founders, between the study variables and the moderating 
effects of tobacco use. Findings from Middleton Fillmore 
et al.92 revealed that there was a significant relationship 
between heavy alcohol consumption after controlling the 
effects of age, study population, design, and study variables. 
Rota et al.95 obtained a significantly higher RR of prostate 
cancer for each drinking alcohol, low (less than or equal to one 
drink per day) and moderate (greater than one and less than 
four drink per day) versus abstaining or occasionally alcohol 
consumption, but the analysis did not show a meaningful rela-
tionship with heavy drinking (greater than or equal to four 
drinks per day). Overall, the findings of recent meta-analysis 
and review studies showed a positive relationship, but none of 
the studies sufficiently controlled the effects of confounding 
variables, including incorrect categorization of former alco-
holics and occasional alcoholics.
Bladder
The role of alcoholic drinks in bladder carcinogenesis has 
been studied in several epidemiologic studies.96,97 According 
to Framingham Heart Study,98 there was no significant rela-
tionship between alcohol consumption and bladder cancer. 
However, the findings of a meta-analysis study of ureteric 
 cancers showed a slight increase of 1.3% for current alcohol-
ic-drinkers compared with non-alcoholic ones.99 The findings 
of specific drinks analyze also revealed uncertain results. Some 
studies have depicted a higher risk for liquor drinks98–101 and 
showed an inverse relationship to beer drink.98,102 The average 
consumption of alcoholic drinks can prevent from coronary 
artery disease, diabetes mellitus,103,104 renal cell carcinoma,105,106 
prostate cancer,107 and NHL108 may be due to mechanisms such 
as improves immune response and increases insulin  sensitivity. 
One of the possible mechanisms of the protective effect of 
alcohol consumption in bladder cancer is the urogenous con-
tact hypothesis.109–111 Meta-analysis study findings showed that 
drinking beer and wine reduces the risk of bladder cancer.112 
Other mechanisms include anti-inflammatory properties of 
alcohol96,113 and anticholinergic effects of polyphenols in red 
wine114 and beer.
Despite the publication of numerous studies in this 
regard, the role of definitive alcohol on bladder cancer, the 
effect of various types of alcoholic drinks, patterns of drinking 
and the role of other factors such as smoking and the fre-
quency of urination for bladder cancer have not yet been 
proven.
Breast
About 4–5% of all breast cancers are associated with alcohol 
consumption, and 60% of alcohol-related tumors in women 
are breast cancer.118 Several epidemiological studies have 
shown a positive relationship between alcohol consumption 
and breast cancer.119,120 This risk occurs even with the average 
consumption of alcohol. For increasing the amount of ethanol 
consumed daily by 10 g, RR growth by 10%.119,121
Kwan et al.122 found that the risk of recurrence of breast 
cancer significantly increased in women who had been breast 
cancer before (especially after menstruation), taking three to 
four times per week. Systematic study findings showed that 
alcohol consumption could extend the risk of breast cancer, 
especially in postmenopausal women.123 The pathogenic 
mechanism of the disease was certainly due to oxidative stress 
induced by acetaldehyde and nutritional changes (folate, 
Vitamin B6 and B12), but the main cause of it is interaction 
with estrogen. It is known that estrogen is metabolized by 
ADH and therefore acts in competition with ethanol. Espe-
cially high concentrations of acetaldehyde are associated with 
high levels of estrogen during the menstrual cycle.43
Endometrium
A cohort study found that alcohol consumption of two units 
or more could increase the risk of endometrial cancer in 
women after menstruation. However, there was no such rela-
tionship in people who consume less than one drink or one to 
two drinks per day.124 The role of unopposed estrogens in 
endometrial cancer etiology has been confirmed.125
Daily use of alcohol is associated with high levels of circu-
lating estrogen in postmenopausal women.126–128 Alcohol con-
sumption also raise the estrogen levels in postmenopausal 
women with estrogen replacement therapy.129,130 Therefore, it is 
likely that women drinking alcoholic drinks are at enhanced 
risk for endometrial cancer. However, the findings of a pro-
spective study between the 1980s and 2010 on 6807 women 
who participated in the study found that drinking <5 g daily 
(about half a day) would reduce the risk of endometrial cancer 
by 22% (multivariable RR = 0.78; 95% CI: 0.66–0.94). Getting 
more alcohol does not; however, produce a protective effect 
against endometrial cancer [multivariable RRs for 5–14.9 g 
(one drink), 15–29.9 g (two drinks), or ≥30 g (two drinks)] 
versus 0 g per day were 0.88, 0.83, and 0.78 (95% CI: 
0.49–1.25), respectively.131
Renal Colon Carcinoma
The implications of a meta-analysis study on 15 case-control 
studies revealed an inverse relationship between alcohol con-
sumption and renal cell carcinoma (OR 0.67, 95% CI: 0.62–0.73). 
The dose–response meta-analysis manifested that an increase 
in alcohol consumption of 12 g of ethanol per day was associ-
ated with a significant reduction of 5% risk of renal cell 
carcinoma.132
Other study findings from 12 prospective studies also 
indicated an inverse relationship between alcohol consump-
tion and renal cell carcinoma.133
The findings of another meta-analysis study in 2012 
showed an inverse relationship between alcohol consumption 
and renal cell carcinoma in both genders. It was also observed 
that drinking one drink per day has protective effects, but 
drinking too much does not have protective effects.134
Brain tumor
Alcohol is able to cross the cerebrospinal fluid and is therefore 
a risk factor for brain cancer.135,136 Ethanol is oxidized to acet-
aldehyde which is a genotoxic metabolite in the brain.137 
Alcohol consumption is in relation to the risk of brain cancer 
238 J Contemp Med Sci | Vol. 5, No. 5, September-October 2019: 234–241
Alcohol consumption and types of cancer: a review
Review
M. Afshar et al.
in adults has been studied in a number of studies from the 
early 1970s138 and usually inconsistent findings revealed in 
both general use and for various types of alcoholic drinks. For 
instance, the findings of a cohort study on glioblastoma, which 
is a type of brain cancer with a low survival rate, showed that 
there is a dose risk with increasing alcohol consumption for 
this cancer.139 This finding was similar for beer and wine. On 
the other hand, according to a study of 908 cases of brain 
cancer, there was no correlation between alcohol consumption 
and brain cancer, and a relative risk of 1.17 reported for taking 
more than 15 drinks per week compared with drinking occa-
sionally (for example less than two drinks per week).140 
 Systematic and meta-analytical findings from 19 studies 
involving 4200 cases of brain cancer suggest that there is no 
significant relationship between alcohol consumption and 
adult brain cancer, although further studies are needed to 
investigate the potential effects of high doses of alcohol.141 
Findings of another meta-analysis study on 19 observational 
studies showed that there is no significant relationship between 
alcohol consumption and the risk of glioma.142
Non-Hodgkin’s Lymphoma
According to The Monograph 96 of the IARC, published in 
2007,135 the risk of NHL in alcohol users was lower than those 
who did not consume alcohol. Similar results were obtained by 
the next IARC.143 In addition, the World Cancer Research Fund 
(WCRF) reported that there was an inverse relationship between 
drinking alcohol and NHL.143 The results of a meta-analysis 
study manifested that the risk of NHL among alcohol users is 
15% less than those who do not consumed alcohol.144
Conclusion
The purpose of this review study was to investigate the associ-
ation between alcohol consumption and the incidence of 
common cancers. Based on the results of studies, alcohol is 
associated with a reduction in the risk of renal cell carcinoma 
and NHL. Conversely, alcohol is a risk factor for oral and tho-
racic cancers, larynx, esophagus, stomach, colorectal, liver and 
breast. However, further studies are needed to confirm defini-
tively the association between alcohol and the development of 
pancreatic, lung, prostate, bladder, endometrial and brain 
tumors. Given the role of excessive alcohol consumption in the 
occurrence of various types of cancers, there is a necessity for 
planning a comprehensive project for alcohol abuse in the 
community.
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